$Beam Therapeutics (BEAM.US)$$Sana Biotechnology (SANA.US)$ ...

SANA announced an initial payment of 50M using Beam's Cas12b system.

It's great for Beam that Cas12b, which Beam doesn't use, is being asked for. The strangest thing is that SANA only needs Cas12b, not Base Editor. It's hard to understand! ?